StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
48
This year
5
Publishing Date
2024 - 03 - 27
1
2024 - 02 - 29
1
2024 - 02 - 14
1
2024 - 01 - 17
1
2024 - 01 - 15
1
2023 - 12 - 12
1
2023 - 09 - 13
1
2023 - 08 - 02
1
2023 - 07 - 07
1
2023 - 06 - 12
1
2023 - 04 - 05
1
2023 - 03 - 10
1
2023 - 03 - 06
1
2023 - 02 - 17
1
2023 - 01 - 16
1
2023 - 01 - 05
1
2022 - 12 - 01
1
2022 - 11 - 18
1
2022 - 11 - 09
1
2022 - 11 - 08
1
2022 - 10 - 11
1
2022 - 10 - 07
1
2022 - 10 - 06
1
2022 - 09 - 19
2
2022 - 09 - 14
1
2022 - 07 - 25
1
2022 - 07 - 19
1
2022 - 06 - 21
1
2022 - 05 - 27
1
2022 - 05 - 23
1
2022 - 03 - 04
1
2021 - 11 - 11
1
2021 - 11 - 02
1
2021 - 10 - 29
1
2021 - 10 - 20
1
2021 - 08 - 10
1
2021 - 08 - 09
1
2021 - 08 - 05
1
2021 - 08 - 04
1
2021 - 07 - 08
1
2021 - 04 - 30
1
2021 - 04 - 16
1
2021 - 04 - 14
1
2021 - 04 - 13
1
2021 - 04 - 12
1
2021 - 04 - 08
1
2021 - 03 - 16
1
Sector
Communications
1
Consumer non-durables
1
Electronic technology
1
Health services
1
Health technology
48
Manufacturing
6
N/a
2
Producer manufacturing
1
Tags
Alzheimer's
1
America
1
Antibody
1
Application
1
Approval
2
Association
1
Authorized
1
Autoimmunity
1
Biocanada
1
Bion-1301
1
Biosimilar
1
Business
1
Cancer
2
Covid
1
Covid-19
1
Diagnostic
1
Disease
6
Distribution
2
Drug
8
Drug delivery
1
Dry eye
2
Entresto
1
Eye
3
Eye disease
1
Fda
2
Fda approval
2
Fda-approvals
1
Financial
2
Financial results
2
Gilenya
1
Global
15
Growing
2
Growth
10
Igan
1
Infection
1
Infections
2
Injection
2
Integration
1
Investments
1
Leukemia
1
License
1
Liver
1
Market
23
Media
1
Momentum
1
Myeloid leukemia
1
N/a
44
Nephropathy
1
News
1
Novartis
2
Patent
2
Pharma
2
Reach
3
Report
10
Research
3
Respiratory
2
Results
5
Therapeutics
4
Therapy
3
Treatment
6
Entities
3m company
1
Abbott laboratories
6
Abbvie inc.
13
Actinium pharmaceuticals, inc.
1
Alkermes plc
1
Amgen inc.
6
Anika therapeutics inc.
1
Aravive, inc.
1
Astellas pharma inc
2
Astrazeneca plc
8
Bausch health companies inc.
2
Biogen inc.
1
Boston scientific corporation
2
Bristol-myers squibb company
2
Chinook therapeutics, inc.
1
Csl ltd
1
Denali therapeutics inc.
1
Eli lilly and company
7
Endo international plc
1
Erasca inc
1
Evelo biosciences, inc.
1
General electric company
1
Gilead sciences, inc.
1
Glaxosmithkline plc
10
Grifols sa
1
Humanigen, inc.
1
Illumina, inc.
1
Johnson & johnson
14
Laboratory corporation of america holdings
1
Mallinckrodt plc
2
Neurocrine biosciences, inc.
1
Novartis ag
48
Novo nordisk a/s
2
Opko health, inc.
1
Orange
1
Pfizer, inc.
1
Prestige consumer healthcare inc.
1
Reckitt benckiser group plc
1
Regenxbio inc.
3
Sanofi
14
Solid biosciences inc.
1
Spectrum pharmaceuticals, inc.
1
Terumo corp
1
Teva pharmaceutical industries ltd
8
Thermo fisher scientific inc
3
Ucb s.a.
1
Ultragenyx pharmaceutical inc.
2
Uniqure n.v.
1
Viatris inc.
3
Viewray, inc.
1
Y-mabs therapeutics, inc.
1
Symbols
AAPL
34
ABB
38
ABBV
49
ABLZF
33
ABT
66
AMGN
43
APO
47
ARVL
200
BMO
39
BNPQF
109
BNPQY
109
CM
29
CNXC
52
CYTK
31
DUK
35
ERIC
38
EXPR
38
EXTR
40
FE
57
FNCTF
336
FRBA
44
FST
34
GE
37
HII
33
HON
53
HUBS
48
ICFI
30
INTC
39
IVA
37
JNJ
180
LLY
46
LTUM
34
LYV
50
MDT
42
MIDD
32
MMM
30
MS
224
MSFT
45
NDAQ
39
NOC
36
NOK
105
NOKBF
109
NVS
48
NVSEF
35
OOMA
46
ORCL
37
POOL
53
PPRUF
35
PPRUY
35
QGEN
30
RY
44
SAP
34
SAPGF
32
SNOW
85
SNY
150
SNYNF
118
TMO
44
TOL
53
VZ
32
WHR
41
Exchanges
Amex
1
Nasdaq
41
Nyse
48
Crawled Date
2024 - 03 - 27
1
2024 - 02 - 29
1
2024 - 02 - 14
1
2024 - 01 - 17
1
2024 - 01 - 15
1
2023 - 12 - 12
1
2023 - 09 - 13
1
2023 - 08 - 02
1
2023 - 07 - 07
1
2023 - 06 - 12
1
2023 - 04 - 05
1
2023 - 03 - 10
1
2023 - 03 - 06
1
2023 - 02 - 17
1
2023 - 01 - 16
1
2023 - 01 - 05
1
2022 - 12 - 01
1
2022 - 11 - 18
1
2022 - 11 - 09
1
2022 - 11 - 08
1
2022 - 10 - 11
1
2022 - 10 - 07
1
2022 - 10 - 06
1
2022 - 09 - 19
2
2022 - 09 - 14
1
2022 - 07 - 25
1
2022 - 07 - 19
1
2022 - 06 - 21
1
2022 - 05 - 27
1
2022 - 05 - 23
1
2022 - 03 - 04
1
2021 - 11 - 11
1
2021 - 11 - 02
1
2021 - 10 - 29
1
2021 - 10 - 20
1
2021 - 08 - 10
1
2021 - 08 - 09
1
2021 - 08 - 05
1
2021 - 08 - 04
1
2021 - 07 - 08
1
2021 - 04 - 30
1
2021 - 04 - 16
1
2021 - 04 - 14
1
2021 - 04 - 13
1
2021 - 04 - 12
1
2021 - 04 - 08
1
2021 - 03 - 16
1
Crawled Time
00:00
45
00:20
10
01:00
47
01:08
1
02:00
25
03:00
34
04:00
23
04:20
8
05:00
23
06:00
69
06:03
2
07:00
39
08:00
34
08:20
4
08:23
1
09:00
45
10:00
33
11:00
52
11:01
1
12:00
83
12:15
6
12:20
16
12:30
9
13:00
35
13:14
1
13:15
7
13:20
8
13:30
5
13:35
1
13:58
1
14:00
50
14:15
2
14:20
10
14:30
7
14:49
1
15:00
55
15:15
4
15:20
16
15:30
16
16:00
56
16:01
1
16:20
4
17:00
65
18:00
55
19:00
45
20:00
48
20:20
3
21:00
34
22:00
55
22:01
1
23:00
44
23:09
1
Source
www.biospace.com
4
www.globenewswire.com
6
www.prnewswire.com
38
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
NVS
crawled time :
20:00
save search
Erasca Reports Fourth Quarter 2023 and Full Year 2023 Business Updates and Financial Results
Published:
2024-03-27
(Crawled : 20:00)
- globenewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-2.13%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
ERAS
|
$1.79
0.0%
570K
|
|
-13.11%
|
O:
17.48%
H:
6.94%
C:
-14.88%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-1.59%
|
O:
0.52%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-6.67%
|
O:
0.28%
H:
1.71%
C:
-0.3%
business
year
financial
results
Urinary Tract Infection Treatment Market Projected to Reach US$ 10.73 Billion by 2030: Telemedicine Integration Revolutionizes UTI Care, Self-Care Products Gain Momentum
Published:
2024-02-29
(Crawled : 20:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
-3.76%
|
O:
-2.33%
H:
3.68%
C:
2.44%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-7.38%
|
O:
0.89%
H:
0.0%
C:
0.0%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-6.55%
|
O:
1.03%
H:
0.14%
C:
0.05%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-8.35%
|
O:
0.28%
H:
0.0%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-5.13%
|
O:
0.26%
H:
0.18%
C:
0.05%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-3.59%
|
O:
0.37%
H:
0.27%
C:
-0.1%
integration
reach
momentum
infection
treatment
market
Global Biosimilar Monoclonal Antibodies Market Report 2024: Future Market Growth Powered by Biologics and Personalized Therapy Advances
Published:
2024-02-14
(Crawled : 20:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-4.06%
|
O:
1.95%
H:
0.0%
C:
0.0%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-4.73%
|
O:
0.26%
H:
0.87%
C:
0.32%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-3.91%
|
O:
0.48%
H:
1.56%
C:
1.48%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-7.29%
|
O:
-0.75%
H:
0.86%
C:
0.41%
biosimilar
report
global
therapy
growth
market
Global Orphan Drugs Market Research Report 2023: Market to Reach $415.2 Billion by the End of 2028 - Premium Pricing of Orphan Drugs and Increasing Collaborations/Licensing Agreements Bolsters Growth
Published:
2024-01-17
(Crawled : 20:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-9.12%
|
O:
0.1%
H:
0.76%
C:
0.76%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
1.64%
|
O:
1.06%
H:
0.0%
C:
-2.34%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-12.65%
|
O:
0.0%
H:
0.0%
C:
0.0%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-19.01%
|
O:
-0.6%
H:
0.34%
C:
0.34%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-12.84%
|
O:
-0.78%
H:
0.59%
C:
0.57%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-7.71%
|
O:
-0.21%
H:
0.0%
C:
0.0%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
2.7%
|
O:
-0.54%
H:
1.55%
C:
1.33%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-10.34%
|
O:
-1.1%
H:
1.63%
C:
1.59%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
3.47%
|
O:
-0.51%
H:
1.33%
C:
0.93%
report
reach
research
global
growth
market
Global Antibody Fragments Market Research Report 2023: Market to Reach $9.6 Billion by 2028 - Increasing Investments in Biopharmaceuticals Driving Growth
Published:
2024-01-15
(Crawled : 20:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-12.55%
|
O:
-2.03%
H:
0.05%
C:
0.05%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-12.18%
|
O:
0.16%
H:
0.43%
C:
0.07%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
12.97%
|
O:
0.15%
H:
0.59%
C:
-1.45%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
2.22%
|
O:
-0.49%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-11.59%
|
O:
-1.34%
H:
0.0%
C:
0.0%
investments
report
antibody
reach
research
global
growth
market
Alzheimer's Disease Therapeutics Market size to grow by USD 5.41 billion from 2023-2028; North America to account for 39% of market growth - Technavio
Published:
2023-12-12
(Crawled : 20:00)
- prnewswire.com
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
28.85%
|
O:
-10.21%
H:
0.0%
C:
0.0%
GIKLY
|
$4.58
132.75%
820
|
Manufacturing
|
-38.8%
|
O:
2.92%
H:
0.0%
C:
0.0%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-3.88%
|
O:
0.71%
H:
0.88%
C:
0.85%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
8.59%
|
O:
-0.17%
H:
1.17%
C:
0.86%
DNLI
|
$15.98
-3.74%
-3.88%
1.5M
|
Health Technology
|
-17.06%
|
O:
2.9%
H:
8.82%
C:
8.56%
BIIB
|
$194.39
2.03%
1.99%
1.6M
|
Health Technology
|
-21.95%
|
O:
0.09%
H:
2.58%
C:
2.52%
america
disease
alzheimer's
therapeutics
growth
market
Scinai Immunotherapeutics Innovative Plaque Psoriasis Treatment Shows Encouraging Preclinical Results
Published:
2023-09-13
(Crawled : 20:00)
- globenewswire.com
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-6.37%
|
O:
0.28%
H:
1.0%
C:
0.76%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
22.14%
|
O:
0.77%
H:
0.43%
C:
-1.27%
psoriasis
treatment
preclinical
results
REGENXBIO Reports Second Quarter 2023 Financial Results and Recent Operational Highlights
Published:
2023-08-02
(Crawled : 20:00)
- prnewswire.com
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-8.17%
|
O:
-1.38%
H:
0.77%
C:
0.7%
RARE
|
News
F
|
$42.37
-2.33%
-2.38%
680K
|
Health Technology
|
0.05%
|
O:
0.0%
H:
0.85%
C:
-2.48%
RGNX
|
$15.67
-2.73%
-2.87%
570K
|
Health Technology
|
-16.98%
|
O:
-7.2%
H:
10.26%
C:
-0.34%
financial
results
Novartis will appeal to U.S. Court of Appeals to uphold validity of Entresto® combination patent; maintains 2023 guidance and mid-term outlook
Published:
2023-07-07
(Crawled : 20:00)
- globenewswire.com
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
entresto
novartis
Chinook Therapeutics to Present Updated Data from Zigakibart (BION-1301) Phase 1/2 Trial in Patients with IgA Nephropathy (IgAN) at the 60th European Renal Association (ERA) Congress
Published:
2023-06-12
(Crawled : 20:00)
- globenewswire.com
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-5.64%
|
O:
-0.26%
H:
0.15%
C:
-0.42%
KDNY
|
$40.39
0.22%
-0.17%
0
|
Health Technology
|
6.35%
|
O:
-0.21%
H:
0.26%
C:
-0.08%
bion-1301
nephropathy
association
renal
trial
therapeutics
igan
Sarcoidosis therapeutics market size to grow by USD 64.82 million from 2021 to 2026: Rising awareness about sarcoidosis to boost the market - Technavio
Published:
2023-04-05
(Crawled : 20:00)
- prnewswire.com
MNK
|
$0.3402
-0.06%
540K
|
n/a
|
-93.17%
|
O:
0.17%
H:
0.17%
C:
-7.04%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
18.22%
|
O:
1.0%
H:
0.63%
C:
0.21%
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
14.8%
|
O:
1.02%
H:
0.45%
C:
0.2%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-0.75%
|
O:
1.34%
H:
0.23%
C:
-0.08%
therapeutics
market
Global Best Selling Pharmaceutical Drugs Analysis Report 2023: Revenue Forecast of the Top 50 Pharmaceutical Drugs and Assessment of their Regulatory Landscape through 2021
Published:
2023-03-10
(Crawled : 20:00)
- prnewswire.com
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
Email alert
Add to watchlist
CSLLY
|
$86.918
3.3%
60K
|
n/a
|
Email alert
Add to watchlist
MNK
|
$0.3402
-0.06%
540K
|
n/a
|
Email alert
Add to watchlist
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
Email alert
Add to watchlist
MNKPF
|
$17.25
|
n/a
|
Email alert
Add to watchlist
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
Email alert
Add to watchlist
ENDP
|
$0.2926
-9.6%
|
Health Technology
|
Email alert
Add to watchlist
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
Email alert
Add to watchlist
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
UCBJY
|
$63.676
-4.38%
7.2K
|
Manufacturing
|
Email alert
Add to watchlist
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
ALPMF
|
$9.17
43.47%
16K
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
BHC
|
$8.69
1.05%
0.0%
2.9M
|
Health Technology
|
Email alert
Add to watchlist
UCBJF
|
$126.05
-39.66%
100
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
ENDPQ
|
$0.0006
-50.0%
3.4K
|
n/a
|
Email alert
Add to watchlist
CMXHF
|
$172.54
-19.21%
50
|
n/a
|
Email alert
Add to watchlist
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
Email alert
Add to watchlist
MNKKQ
|
$0.02
|
Manufacturing
|
Email alert
Add to watchlist
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
Email alert
Add to watchlist
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
Email alert
Add to watchlist
global
report
Osteoarthritis therapeutics market to grow at a CAGR of 8.97% from 2022 to 2027: Growth opportunities led by Abbott Laboratories and Alvogen Iceland ehf among others- Technavio
Published:
2023-03-06
(Crawled : 20:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
32.19%
|
O:
-2.12%
H:
0.0%
C:
-1.26%
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
3.59%
|
O:
0.09%
H:
0.18%
C:
-1.29%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
11.12%
|
O:
0.11%
H:
0.05%
C:
-1.21%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
15.38%
|
O:
0.32%
H:
0.17%
C:
-1.53%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
4.41%
|
O:
0.11%
H:
0.23%
C:
-2.8%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-3.0%
|
O:
0.65%
H:
0.0%
C:
0.0%
ANIK
|
$25.84
1.61%
1.59%
49K
|
Health Technology
|
-10.5%
|
O:
-4.29%
H:
1.19%
C:
-6.23%
osteoarthritis
therapeutics
growth
market
Global Global Antimalarial Drugs Market Research Report 2022-2028 Featuring Cipla, GSK, Ipca, Merck, Novartis, Zydus Cadila, Sun Pharma, Strides Pharma, Glenmark Pharma, Lincoln Pharma
Published:
2023-02-17
(Crawled : 20:00)
- prnewswire.com
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
pharma
research
global
report
market
Dry Eye Products Global Market Report 2022: Sector to Reach $9.68 Billion by 2028 at a 5.1% CAGR
Published:
2023-01-16
(Crawled : 20:00)
- prnewswire.com
PBH
|
$69.67
1.93%
0.0%
450K
|
Health Technology
|
4.58%
|
O:
-0.27%
H:
1.52%
C:
-0.9%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
3.62%
|
O:
2.34%
H:
0.04%
C:
-0.87%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
8.34%
|
O:
0.13%
H:
0.85%
C:
-0.63%
global
report
eye
market
Insights on the Allergic Conjunctivitis Global Market to 2031 - by Drug Class, Disease Type, Distribution Channel and Region
Published:
2023-01-05
(Crawled : 20:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
22.58%
|
O:
0.04%
H:
0.0%
C:
-1.84%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
3.92%
|
O:
0.35%
H:
1.43%
C:
1.28%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-17.28%
|
O:
0.74%
H:
0.44%
C:
0.07%
BHC
|
$8.69
1.05%
0.0%
2.9M
|
Health Technology
|
21.37%
|
O:
0.84%
H:
4.71%
C:
3.46%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
1.79%
|
O:
0.83%
H:
1.98%
C:
1.04%
drug
global
disease
distribution
market
Global Epigenetics Market Analysis Report 2022: Growing Prevalence of Cancer and Other Diseases Significantly Driving Growth
Published:
2022-12-01
(Crawled : 20:00)
- prnewswire.com
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
5.05%
|
O:
-1.08%
H:
1.44%
C:
1.28%
global
report
growing
cancer
growth
market
Global Precision Medicine Market to Reach $146.57 Billion by 2028 at a 12.1% CAGR
Published:
2022-11-18
(Crawled : 20:00)
- prnewswire.com
ILMN
|
$117.43
0.63%
0.63%
1.4M
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
TMO
|
News
|
$544.78
0.6%
0.0%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
LH
M
|
$201.48
1.02%
0.0%
770K
|
Health Services
|
Email alert
Add to watchlist
global
market
Worldwide Radiotheranostics Industry to 2027 - By Radioisotope, Application, End-user, Competitive Landscape and Region
Published:
2022-11-09
(Crawled : 20:00)
- prnewswire.com
TRUMF
|
$16.928
-17.59%
1.9K
|
Health Technology
|
-42.43%
|
O:
2.88%
H:
1.93%
C:
-0.99%
TRUMY
|
$16.507
0.79%
34K
|
Manufacturing
|
-43.89%
|
O:
0.27%
H:
3.27%
C:
3.27%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
13.73%
|
O:
2.81%
H:
0.43%
C:
-0.2%
BSX
|
$67.33
-0.13%
-0.31%
7M
|
Health Technology
|
60.08%
|
O:
3.26%
H:
1.01%
C:
0.76%
YMAB
|
$15.15
1.0%
0.99%
470K
|
Health Technology
|
275.43%
|
O:
4.96%
H:
9.22%
C:
9.22%
SPPI
|
$1.03
-0.97%
0
|
Health Technology
|
152.82%
|
O:
5.57%
H:
9.88%
C:
7.49%
ATNM
|
$6.85
2.7%
0.0%
350K
|
Health Technology
|
-38.73%
|
O:
3.4%
H:
3.63%
C:
2.25%
Pleurodynia Treatment Market Size to USD 24.61 Mn, Growing Prevalence of Viral Infections to Boost Market Growth - Technavio
Published:
2022-11-08
(Crawled : 20:00)
- prnewswire.com
RBGPF
|
$51.61
6.46%
4.7K
|
Consumer Non-Durables
|
-19.56%
|
O:
-1.91%
H:
4.89%
C:
0.2%
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
29.99%
|
O:
3.44%
H:
0.0%
C:
-3.27%
RBGLY
|
$10.35
-2.05%
990K
|
Manufacturing
|
-20.87%
|
O:
-1.61%
H:
1.0%
C:
-0.16%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
15.31%
|
O:
0.84%
H:
1.22%
C:
0.55%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
23.37%
|
O:
0.06%
H:
1.27%
C:
0.56%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
7.67%
|
O:
0.27%
H:
1.36%
C:
-0.45%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
7.35%
|
O:
0.72%
H:
0.69%
C:
-0.23%
treatment
growing
infections
growth
market
← Previous
1
2
3
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.